Skip NavigationSkip to Content

Reversal of p53-induced cell-cycle arrest

  1. Author:
    Bates, S.
    Hickman, E. S.
    Vousden, K. H.
  2. Author Address

    Bates S NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program Bldg 560,Room 22-96,W 7th St Frederick, MD 21702 USA NCI, Frederick Canc Res & Dev Ctr, ABL Basic Res Program Frederick, MD 21702 USA
    1. Year: 1999
  1. Journal: Molecular Carcinogenesis
    1. 24
    2. 1
    3. Pages: 7-14
  2. Type of Article: Article
  1. Abstract:

    Activation of the tumor suppressor protein p53 can lead to arrest in both G(1) and G(2) stages of the cell cycle and, in some cells, to apoptotic cell death. In this study, we showed that the p53 response to a chemotherapeutic drug, actinomycin D, was reversible in both normal and tumor cells, even when a substantial proportion of tumor cells were undergoing apoptosis. Despite the clear reversibility of the p53-induced cell-cycle arrest after removal of actinomycin D, a substantial proportion of the cells arrested in G(2) failed to resume normal cell-cycle progression and underwent another round of DNA synthesis. This endoreduplication probably reflects a function of the cyclin-dependent kinase inhibitor p21(Waf1/Cip1), which is expressed in response to p53. Our observation that this abnormal re-replication of DNA occurred in both transformed and untransformed cells after reversal of a p53 response may have implications for the eventual outcome of tumor therapies in which p53 is transiently expressed in a substantial number of normal as well as tumor cells. Published 1999 Wiley-Liss, Inc. [References: 34]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel